GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract HHSN272200800062CPROFECTUS BIOSCIENCES, INC.

Overview

Award facts

Net obligations
$19.19M
$19,188,157of $19.19M potential value
Period of performance
Jan 10, 2017 to Dec 31, 2013
Ended
Modifications
6
Latest action Jan 10, 2017
Contract type
Definitive contract
PIID HHSN272200800062C

Description of requirement

THERAPEUTIC IMMUNIZATION AGAINST HIV WITH ADJUVANT-ENHANCED DNA AND MULTI-EPITOPE PEPTIDE VACCINES

Dates and value

Award date
Signed on Sep 17, 2008
Potential end of performance
Dec 30, 2013
Current value
$19,188,157Base and exercised options
Potential value (if all options are exercised)
$19,188,157

Obligations by fiscal year of action

  • FY2017: -$8,888 (de-obligation)
  • FY2013: $25,800
  • FY2012: $1,306,067
  • FY2011: $292,954
  • FY2009: $12,110,276
  • FY2008: $5,461,948

Total across 6 fiscal years: $19,188,157

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 10, 2017. View on USAspending · Recipient on SAM.gov

Recipient

LocationBALTIMORE, MD
UEIDDRUDKNS37N8
Business sizeSmall businessSize at award, per the contracting officer

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Baltimore, Baltimore City, Maryland 21224-6538
Congressional district (place of performance)
MD-07As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
19

Solicitation and notices

Solicitation ID
NIHNIAIDDAIDS0442(as reported)

Contract details

Subcontracting plan
Plan not requiredB
Major program
Hiv vaccine design and development teams
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial item procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 17, 2008Base obligation at award: $5,461,948
Latest action
Jan 10, 2017 — Funding onlyModification 6; obligation change -$8,888; funding only: changes obligations, not scope
Latest substantive action
Sep 14, 2012 — Change orderModification 3; obligation change +$1,306,067
Latest funding action
Jan 10, 2017 — Funding onlyModification 6; obligation change -$8,888; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Funding only3
  • Change order2
  • Other administrative action1
7 actions recorded, Sep 17, 2008 to Jan 10, 2017; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$8,888
Latest action: change in base and all options
-$8,888

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
7

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2012/2012-0885-000
Object classes
  • 25.5: Research and development contracts